Julphar sees 11% growth in H1

Source: News Source

UAE-based pharmaceutical firm Julphar registered Dhs696.4 million revenue in the first six months of 2013, up 10.5% year-on-year (yoy). Sales during the period were driven by the private market sales which saw a yoy growth of 13.4%. The firm continued to show good operational performance during the period. Gross Profit during the period was Dhs412.1 million, up 8.3% yoy. Operating Profit for the period, on the other hand, was Dhs126.5 million, up 2.8% yoy. Operating profit margin during the period was a robust 18.2%. Profit for the period was Dhs116.9 million, up 5.5% yoy.